Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Cymer (CYMI) -- Ignore unavailable to you. Want to Upgrade?

To: Zeev Hed who wrote (17339)	5/4/1998 7:24:00 PM
From: Starlight	Read Replies (1) \| Respond to of 25960

Off-Topic - Zeev - I heard an analyst talk about ENMD on CNBC today, and he said that he feels ENMD is NOT overpriced at current levels. He says they are in human trials on Thalidomide as a cancer treatment (Phase I, I believe), and that drug is also promising. All in all, I believe he said they had 4 cancer drugs. (I'm not trying to hype ENMD - don't own any, don't intend to buy it.) If you recall, some years ago, Thalidomide - a tranquilizer, if I remember correctly - was taken by pregnant women, and they produced children with no arms and legs or stunted arms and legs. The drug stopped development of the fetus. Now they are using it to stop development of tumors. Betty